Search Results - "Carratalá, V. Pallarés"

Response to «Security and effectivity from the dapagliflozin with other inhibitor of the SGLT-2: What decision to take? by Pallarés Carratalá, V, Escobar Cervantes, C

Get full text

Renal pathophysiology and pharmacological mechanisms of nephroprotection by Górriz, J L, Górriz-Zambrano, C, Pallarés-Carratalá, V

“…Several risk factors may affect the progression of chronic kidney disease (CKD). Arterial hypertension, proteinuria, obesity, intraglomerular hypertension,…”
Get full text

COVID-19 and cardiovascular and kidney disease: Where are we? Where are we going? by Pallarés Carratalá, V, Górriz-Zambrano, C, Morillas Ariño, C, Llisterri Caro, J L, Gorriz, J L

“…The SARS-CoV-2 pandemic is a global health emergency and we need to know more about it. Patients with cardiovascular risk and previous kidney risk have been…”
Get full text

ARTERIAL HYPERTENSION, CLINICAL CHARACTERISTICS OF PATIENTS INCLUDED IN THE IBERICAN STUDY by Piera Carbonell, A.M, Prieto Díaz, M.A, Cinza Sanjurjo, S, Micó Perez, R.M, Pallarés Carratalá, V, Barquilla García, A, Llisterri Caro, J.L, Polo García, J, Romero Secin, A, González Gamarra, A, Zambrana Calví, G.D.R, Lasso Oria, V, Piñeiro Díaz, C, Gómez Montes, C, Gil Gil, I, Murillo Jelsbak, C, Panisello Royo, J.M, Gómez González, M.J, Pinto Pena, L, Ruiz García, A

“…OBJECTIVE:The general objectives of IBERICAN are to determine the prevalence and incidence of cardiovascular risk factors in Spain, as well as cardiovascular…”
Get full text

SEMERGEN positioning on approaching chronic heart failure in primary care by Castillo Moraga, M J, Turégano-Yedro, M, Pallarés-Carratalá, V, Seoane-Vicente, M C, Serrano Cumplido, A, Ruiz-García, A, Martin-Rioobó, E, Escobar-Cervantes, C, Polo-García, J, Barrios, V

“…Heart failure (HF) is a public health problem that generates a large healthcare burden both in hospitals and in Primary Care (PC). The publication of numerous…”
Get full text

Statement of the Spanish Interdisciplinary Vascular Prevention Committee on the updated European Guidelines on Cardiovascular Disease Prevention by Brotons, C, Camafort, M, Del Mar Castellanos, M, Clarà, A, Cortés, O, Diaz Rodriguez, A, Elosua, R, Gorostidi, M, Hernández, A M, Herranz, M, Justo, S, Lahoz, C, Niño, P, Pallarés-Carratalá, V, Pedro-Botet, J, Pérez Pérez, A, Royo-Bordonada, M A, Santamaria, R, Tresserras, R, Zamora, A, Zuza, I, Armario, P

“…Statement of the Spanish Interdisciplinary Vascular Prevention Committee on the updated European Guidelines on Cardiovascular Disease Prevention. We present…”
Get more information

Home blood pressure self-measurement: “Current situation and new perspectives” by Divisón-Garrote, J.A., Velilla-Zancada, S., Artigao-Rodenas, L.M., García-Lerín, A., Vicente-Molinero, A., Piera Carbonell, A.M., Alonso-Moreno, F.J., Crespo-Sabarís, R., Valls-Roca, F., Martín-Rioboó, E., Pallarés-Carratala, V.

“…The method typically used to diagnose and monitor hypertensive patients has been to measure blood pressure in the physician's surgery; however, it is a…”
Get full text

Prognostic utility of electrocardiograms in patients with hypertension older than 65 years. The PAFRES study by Guedes Ramallo, P, Morillas Blasco, P, Gómez Martínez, M J, Núñez Martínez, L, Romero Valero, A, Peris Castelló, F, Rodríguez Santiago, F M, Vicente Ibarra, N, Quintanilla Tello, M A, Castilla Cabanes, E, Fácila Rubio, L, Pallarés-Carratalá, V

“…OBJECTIVELeft ventricular hypertrophy is the most common marker of target organ damage in arterial hypertension. Electrocardiograms are typically performed to…”
Get full text

Evaluation of prophylaxis in primary prevention with acetylsalicylic acid in people with diabetes: A scoping review by Ruiz-García, A., Pallarés-Carratalá, V., Serrano-Cumplido, A., Escobar-Cervantes, C., Barquilla-García, A., Divisón-Garrote, J.A., Turégano-Yedro, M., Prieto-Díaz, M.A., Cinza-Sanjurjo, S., Alonso-Moreno, F.J., Beato-Fernández, P., García-Matarín, L., Rey-Aldana, D., Martín-Rioboó, E., Moyá-Amengual, A., Crespo-Sabarís, R., Piera-Carbonell, A., Romero-Vigara, J.C., Carrasco-Carrasco, E., Velilla-Zancada, S., Seoane-Vicente, M.C., Górriz-Teruel, J.L., Polo-García, J., Barrios, V.

“…The efficacy and safety of acetylsalicylic acid (ASA) prophylaxis for the primary prevention of atherosclerotic cardiovascular disease (ACVD) remain…”
Get full text

Prevalence of obesity and cardiovascular comorbidity associated in patients included in the IBERICAN study by Cinza Sanjurjo, S, Prieto Díaz, M Á, Llisterri Caro, J L, Barquilla García, A, Rodríguez Padial, L, Vidal Pérez, R, Rodríguez Roca, G C, Badimón Maestro, J J, Pallarés Carratalá, V

“…To analyse the prevalence of obesity and its association with other cardiovascular risk factors and cardiovascular disease in a sample of patients from the…”
Get full text

Positioning for the management of arterial hypertension in Primary Care from the critical analysis of the American (2017) and European (2018) guidelines. Spanish Society of Primary Care Physicians (SEMERGEN) by Pallarés-Carratalá, V, Divisón Garrote, J A, Prieto Díaz, M A, García Matarín, L, Seoane Vicente, M C, Molina Escribano, F, Velilla Zancada, S, Rey Aldana, D, Cinza Sanjurjo, S, Santos Altozano, C, Górriz, J L, Alonso Moreno, F J, Polo García, J, Barquilla García, A, Beato Fernández, P, Escobar Cervantes, C

“…The Scientific Societies of Primary Care, being the area in which there is a considerable prevalence of Arterial Hypertension (AHT), need to periodically…”
Get full text

Tratando las arterias: ecografía 3 D carotídea y femoral, más allá de la ecografía 2D by Frías Vargas, M, Franco, O.H, Pallarés Carratalá, V

Get full text

Prevalencia de obesidad y comorbilidad cardiovascular asociada en los pacientes incluidos en el estudio IBERICAN (Identificación de la poBlación Española de RIesgo CArdiovascular y reNal) by Cinza Sanjurjo, S, Prieto Díaz, M.Á, Llisterri Caro, J.L, Barquilla García, A, Rodríguez Padial, L, Vidal Pérez, R, Rodríguez Roca, G.C, Badimón Maestro, J.J, Pallarés Carratalá, V

“…ResumenObjetivosAnalizar la prevalencia de obesidad y su asociación con otros factores de riesgo cardiovascular y la enfermedad cardiovascular en una muestra…”
Get full text

Dislipidemia y riesgo vascular. Una revisión basada en nuevas evidencias by Pallarés-Carratalá, V, Pascual-Fuster, V, Godoy-Rocatí, D

“…Resumen La dislipidemia es uno de los principales factores de riesgo de cardiopatía isquémica, primera causa de mortalidad en el mundo. Realizar una detección…”
Get full text

Clinical and practical management of sodium-glucose cotransporter type 2 inhibitors in patients with chronic kidney disease by Castillo Moraga, M J, Turégano-Yedro, M, Pallarés-Carratala, V

“…The discovery of the nephroprotective role of sodium-glucose cotransporter type 2 (iSGLT2) inhibitor drugs in people with type 2 diabetes mellitus (DM 2)…”
Get full text

Posicionamiento para el manejo de la hipertensión arterial en atención primaria a partir del análisis crítico de las guías americana (2017) y europea (2018). Sociedad Española de Médicos de Atención Primaria (SEMERGEN) by Pallarés-Carratalá, V, Divisón Garrote, J.A, Prieto Díaz, M.A, García Matarín, L, Seoane Vicente, M.C, Molina Escribano, F, Velilla Zancada, S, Rey Aldana, D, Cinza Sanjurjo, S, Santos Altozano, C, Górriz, J.L, Alonso Moreno, F.J, Polo García, J, Barquilla García, A, Beato Fernández, P, Escobar Cervantes, C

“…ResumenParece necesario que las sociedades científicas de AP, ámbito en el cual la prevalencia de HTA es considerable, evalúen periódicamente las directrices…”
Get full text

Current situation of direct oral anticoagulants in primary care in Spain: Positioning of SEMERGEN in 2023 by Polo-García, J, Pallares-Carratalá, V, Turegano-Yedro, M, Romero-Vigara, J C, Prieto-Díaz, M A, Cinza-Sanjurjo, S

“…Oral anticoagulation is the key to reduce the risk of stroke in atrial fibrillation. Although vitaminK antagonists (VKA) have classically been used for this…”
Get full text

Analysing the concept of diagnostic inertia in hypertension: a cross-sectional study by Pallares-Carratalá, V, Bonig-Trigueros, I, Palazón-Bru, A, Lorenzo-Piqueres, A, Valls-Roca, F, Orozco-Beltrán, D, Gil-Guillen, V F

“…The aim of this study was to quantify diagnostic inertia (DI) when the physician fails to diagnose hypertension and determine its associated factors. This…”
Get more information

Non-compliance and therapeutic inertia: two unanswered questions in clinical practice by Pallarés-Carratalá, V., Pascual Pérez, R.

Get full text

Global And Cardiovascular Mortality In The Hypertensive And Diabetic Mediterranean Population Older Than 65 Years Old by Tamarit-García, J.J., Roig-Espert, B., González-Cruz-Cervellera, A., Pallarés-Carratalá, V., Morillas-Blasco, P.

Get full text